This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Microsoft 2008 Pharmaceutical and Life Sciences Innovation Awards
Drug reaction death rate doubles
FDA wants more stent safety data
Zevalin gets amber light for treating lymphoma
Specialists warn of heightened OTC risks
Concerns over hospital infections
Covert system “offers hope in war on fakes”
CHMP rejects UCB’s Cimzia for second time
Arthritis treatment “effective”
Study “rules out” MMR autism link
Boehringer issues inhaler warning
Reflections on cancer patients’ “quality of life”
« Previous
1
…
207
208
209
210
211
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: